Kurland J, Franklin S, Goldfinger D
Transfusion. 1980 May-Jun;20(3):337-40. doi: 10.1046/j.1537-2995.1980.20380214903.x.
Therapy for acute renal allograft rejection generally consists of administration of high doses of corticosteroids along with cytotoxic drugs. Failure of this treatment usually dictates removal of the graft. We describe a patient who was rejecting a renal transplant from his HLA-identical, mixed lymphocyte culture-compatible brother. This acute rejection episode was unresponsive to three days of therapy with high doses of steroids, azathioprine and coumadin. The patient rapidly improved following intensive exchange plasmapheresis and lymphocytapheresis. This therapy produced depletion of immunoglobulins, complement components, coagulation factors and circulating lymphocytes, and resulted in dramatic improvement in renal function and reversal of the rejection crisis. We suggest that intensive pheresis may represent an important adjunct to currently available therapy for the treatment of acute renal allograft rejection.
急性肾移植排斥反应的治疗通常包括大剂量皮质类固醇与细胞毒性药物联合使用。若这种治疗失败,通常需要切除移植肾。我们描述了一名患者,他正在排斥来自其 HLA 相同、混合淋巴细胞培养相容的兄弟的肾移植。这次急性排斥反应对大剂量类固醇、硫唑嘌呤和香豆素治疗三天无反应。在进行强化置换血浆分离术和淋巴细胞去除术后,患者病情迅速改善。这种治疗导致免疫球蛋白、补体成分、凝血因子和循环淋巴细胞减少,并使肾功能显著改善,逆转了排斥危机。我们认为强化血液成分单采术可能是目前治疗急性肾移植排斥反应的重要辅助手段。